Funder: National Institutes of Health
Due Dates: May 26, 2025 (Letter of Intent & Open) | June 26, 2025 (Application) | Feb 6, 2026 (Letter of Intent) | Mar 6, 2026 (Application)
Funding Amounts: Up to $100,000 direct costs/year for up to 2 years; max $200,000 direct costs total; ~20 awards anticipated.
Summary: Supports new and early stage investigators in type 1 diabetes (T1D) research by embedding them in major collaborative consortia to foster innovation, networking, and career development.
Key Information: Clinical trials are not allowed; applicants must be New or Early Stage Investigators; affiliation with a listed T1D consortium is required.